SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " bottom " 19,224 found 🔀 AI-powered Shuffle
NFL OTAs: Top 10 storylines, including Ty Simpson's Rams career starting and new looks for Cowboys and 49ers
White Sox rookie Munetaka Murakami finally hit something other than a home run after record-setting start
Tony Awards 2026: 10 standout performances and shows
Moments that stand out from the 2025-2026 Broadway season include two performances by Laurie Metcalf, a radical reframing of 'Cats' and John Lithgow's towering performance in 'Giant.'
Roberto De Zerbi at Tottenham: How new head coach has revitalised Spurs in four matches to turn fortunes around
Castle Shannon restaurant hit with consumer alert by health department
The US said it decimated Iran’s nuclear capabilities. But satellite images show some of it appears to have survived
‘Absolutely’: Congressman whose district is at risk from redistricting says Trump is trying to rig the midterm vote
Ireland Contracting Nightly Sports Call: May 4, 2026
Adam Mockler responds to panelist who calls him ‘ungrateful’ to US service members
How drone warfare is complicating the US military operation against Iran
Anthony Edwards will play in Timberwolves-Spurs Game 1
Lawncare businesses forced to embrace fuel surcharges as Iran war keeps gas prices climbing
How a Minnesota landscaping business is navigating rising gas prices
More Minnesota farmers seeking help to navigate mental health challenges
Olivia Wilde's Met Gala 2026 dress is business in the front, party in the back
Illinois maintains high childhood vaccination rates, health department says
Tarik Skubal's elbow is now MLB's biggest mystery. His recovery time from surgery could be difference between a $250M and $450M deal
New Jersey adds flag football as sanctioned sport for high school girls
Luka Dončić ruled out a day of ahead of Lakers-Thunder Game 1
As Spirit Airlines shuts down, businesses inside Arnold Palmer Regional Airport feel impact
Health Watch: Melanoma Monday - Gen Z survey reveals sunscreen myths & rising skin cancer risks
UT Board of Trustees approves plan for Neyland Entertainment District and new parking project
UT Board of Trustees approves plan for Neyland Entertainment District and new parking project
Bulls hire Bryson Graham as next VP of basketball operations amid search for new GM, head coach
Cavaliers-Pistons: Will Cleveland suffer another second-round exit? Series keys, schedule and prediction
UT board approves plan for Neyland Entertainment District, and 'restructure' of G10 parking garage
Ilitch Sports And Entertainment Hosting Announcement At Little Caesars Wednesday For Anticipated PWHL Detroit Announcement
Ilitch Sports And Entertainment Hosting Announcement At Little Caesars Wednesday For Anticipated PWHL Detroit Announcement
Celebrating Seattle’s small businesses every day
National Small Business Week is a time to celebrate the important contributions of our small businesses to Seattle’s economy. They bring character to our neighborhoods, drive our economy, and embody what makes Seattle special. “Small businesses are the backbone of our economy. For every dollar we invest in a small business, 75 percent comes back […]
Flag football approved as sanctioned sport for high school girls in New Jersey
‘It just is what it is.’ Indiana GOP leader reflects on President Trump’s vow to come after him
Chelsea look like a broken club, says Jamie Carragher after Blues suffer sixth-straight Premier League defeat
Pittsburgh's pro sports teams unite to fight food insecurity with Burgh Proud Challenge
Pittsburgh’s pro sports teams unite to fight food insecurity with Burgh Proud Challenge
Chicago officials celebrate Small Business Week with policies meant to help owners
Chicago officials celebrate Small Business Week
Fantasy Baseball Waiver Wire: Moisés Ballesteros looks like a top hitting streamer this week
Ex-NYC Mayor Rudy Giuliani remains hospitalized with pneumonia as business partner warns: 'Today is an important day'
Registration open for 2027 IU Health 500 Festival Mini-Marathon and Delta Dental 500 Festival 5K
Alisson Becker transfer news: Juventus make Liverpool goalkeeper a top target this summer
Central Indiana communities creating new athletic director roles to oversee youth athletics
AJC poll finds Bottoms leading Georgia’s Democratic race for governor
Former Atlanta Mayor Keisha Lance Bottoms has a big advantage. But about a third of likely Democratic primary voters remain undecided.
Pirates still at the bottom of hotly contested NL Central
Despite an above .500 record against divisional opponents the Pirates are still fifth in the standings.
Global Health & WASH: May 2026 Funding Opportunities (14 new opportunities!)
The May update for Global Health & WASH brings new calls that cluster around three distinct shifts: LMIC research leadership moving from funder encouragement into a hard eligibility constraint, pharmaceutical and corporate-linked funders running structurally independent education and use-inspired research portfolios at substantial scale, and AI adoption shifting decisively from speculative tool to operational capability across health and WASH systems alike. In LMIC Research Leadership as Eligibility, Not Encouragement, Wellcome anchors the dominant signal of the month with three separate major calls that all require or strongly center LMIC leadership in their basic eligibility architecture. Wellcome’s ESIC Hubs (£1.5-£1.9M per hub over 3-5 years) explicitly requires an LMIC-based lead applicant, treating Global South leadership as a design constraint rather than a participation goal. Wellcome’s Infectious Disease Clinical Trial Development Award funds transdisciplinary teams whose lead must be a mid-career or established researcher based at an organization in Africa, South Asia, or Southeast Asia. Wellcome’s larger Infectious Disease Clinical Trial Award (£1M-£8M for optimizing licensed interventions) requires the administering organization to be in eligible LMIC regions and at least 50% of applicants based there. Around Wellcome, the same pattern shows up at smaller scale and across funders: CHINNOVA channels $1M into West and Central African research institutions for climate-health work; IBRO’s Neuroscience Training Grants explicitly tier ceilings by region of residence with Africa receiving the highest amount ($5,000); IHME’s GBD Emerging Researcher Award reserves at least one of its two annual awards for an LMIC researcher; Sidaction’s HIV Cure call funds research teams across France, the Netherlands, and eligible African countries with a minimum two-country collaboration requirement. Taken together, these calls signal a meaningful shift in how research equity is being operationalized — not as encouragement language at the bottom of a call, but as a structural feature of who can lead, where the work must be administered, and what proportion of the team must be regionally rooted. In Pharma-Funded Independent Medical Education and Use-Inspired Research, the lineup this month is unusually deep. Pfizer alone runs four parallel calls under independent education and quality improvement frameworks: a Migraine and Women’s Health RFP (200K x 2-year, $500K pool), Migraine IME ($200K, $1M pool), JAK Inhibitor evidence-based education ($100K), and Maternal Vaccination HCP Education in Saudi Arabia ($75K), plus a separate Pediatric Pneumococcal Surveillance research call in Saudi Arabia ($400K per project). Novo Nordisk Foundation runs four parallel calls of its own at substantial scale: Infectious Diseases Catalyst Grants (DKK 60M pool, up to DKK 7M collaborative), Non-Diabetic Endocrinology Collaborative Grants (DKK 53M pool, DKK 5-10M per project), Pioneer Innovator Grant Health (DKK 1.1M), and Distinguished Innovator Grant Health (DKK 6.8M). LEO Foundation deploys DKK 2-4M per project for dermatology research excellence. Pfizer’s framing across calls deliberately separates the funding from product promotion, emphasizing measurable practice-relevant change and structural distance between scientific outputs and commercial activity. Novo Nordisk’s “use-inspired” hard filter pushes researchers toward a credible translation pathway from mechanism to deployable tool. The pattern: industry-aligned funders are running structurally independent portfolios at meaningful $ that fund implementation evidence, not promotion. In AI as Operational Capability, Not Speculation, several calls this month explicitly treat AI adoption as a near-term operational question with real evidence and governance requirements, rather than a speculative trend to be watched. Wellcome’s ESIC Hubs frames AI as “the accelerator” for evidence synthesis, asking hubs to translate technical innovation into adoption-ready workflows that can match real-world policy timelines. UNICEF Venture Fund’s new Climate Tech for Children’s Health call funds for-profit startups deploying AI, machine learning, and blockchain in low-resource environments, with a strict requirement that solutions must already have a working prototype with promising pilot results. The Water Research Foundation has launched two simultaneous AI calls treating reproducibility, cybersecurity guardrails, and human-in-the-loop deployments as core design constraints rather than nice-to-haves: one on GenAI and Agentic AI in water utilities ($200K), one on alternatives to water shutoffs that explicitly screens for implementation economics evidence. Nordic Innovation’s quantum technology call (NOK 4.5M) extends the same logic into life science and healthcare, demanding consortium-stage projects mature enough to test with real users. TEF-Health offers €300K in subsidized testing infrastructure for European healthcare AI and robotics SMEs. The pattern: funders are converting AI pilots into playbooks, requiring transfer evidence and risk controls before AI can move from experimentation to sector-wide operational practice. For LMIC-based researchers in infectious disease or evidence synthesis, the three Wellcome calls together represent the deepest concentration of LMIC-led research capital in recent memory — pair the Infectious Disease Clinical Trial Development Award (£200K, deadline May 19) as a strategic pipeline feeder into the larger Infectious Disease Clinical Trial Award (£1-£8M, deadline June 2), since the development award functions explicitly as a track into the larger trial scheme. For Nordic researchers, the four Novo Nordisk Foundation calls plus LEO Foundation and Nordic Innovation Quantum represent ~$30M in regional research capital this cycle, all with deadlines clustered in May-August. For WASH practitioners, the three Water Research Foundation calls together (each up to $200K) are a cluster worth reading across — one on AI deployment, one on shutoff alternatives, one rewarding applied innovation — and the strongest applicants will articulate how their work bridges utility operations to policy-relevant evidence. For US-based clinical researchers and educators, the four Pfizer calls plus the APF Portfolio’s 80+ programs form an unusually accessible recurring pipeline; APF’s prohibition on indirect costs is a meaningful structural feature for early-career applicants whose institutions might otherwise absorb significant overhead. Snapshot of New Opportunities Total Estimated Funding Pool: $100 Million+ USD The grants are organized into three categories: Open Calls: Current grant and opportunities with a deadline. Grants are listed by closing date. 39 open opportunities- 14 new! Rolling Applications: current grant and opportunities with rolling applications (but it’s still best to submit as early as possible). 14 rolling opportunities- 1 new opportunity! Long term planning: Grants that have closed their current rounds, but are expected to open new windows. 4 long term opportunities! A quick tip for returning readers: if you want to jump straight to the newest additions, use CTRL F to search for “New!” and navigate quickly to the latest funding opportunities This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities. Subscribe To keep this accessible to everyone who needs it, we’re happy to offer pay what you can rates. You can find more details here. Open Calls: Migraine Competitive Grant Program: Migraine and Women’s Health (Quality Improvement and/or Research RFP), Pfizer.*Closing soon!* Pfizer, in collaboration with the American Headache Society, is seeking independent quality improvement and research projects that close persistent gaps in migraine care for women across the United States. The funding logic centers on measurable, practice-relevant change: proposals should generate actionable evidence, tools, or system improvements that can be shared and used widely, not just within a single site. Priority areas span menstrual migraine and screening in women’s health settings, the role of hormonal fluctuations across the lifespan, sex-specific risk factors, comorbidities and quality-of-life burden, and disparities in outcomes by race, ethnicity, and socioeconomic status. The call is structured as a two-step competitive process with an initial Letter of Intent, with the strongest concepts expected to translate scientific insight into implementable improvements in diagnosis, management, and equity. Geographies: United States. Who can apply: U.S.-based organizations (not individuals), including professional schools, healthcare institutions, professional organizations, and other entities focused on healthcare improvement. Funding amount: Up to USD $200,000 total over 2 years; total pool USD $500,000. Targeted Sectors / SDGs: Health; Focus areas: migraine, women’s health, quality improvement, clinical research, menstrual migraine, health disparities. Deadline: LOI: May 5, 2026; Full proposal (by invitation): August 28, 2026. Learn more and apply here. This RFP rewards “shareable impact”: the most competitive submissions will pair rigorous methods with a clear plan for system uptake and dissemination beyond the originating institution. ReSSARC: Strengthening the Health Sector and Food Security in the Central African Republic (AID 013381/01/0) Call for Proposals, Italian Agency for Development Cooperation (AICS). *Closing soon!* AICS is seeking a limited set of high-capacity humanitarian partners to deliver an integrated package that stabilizes essential health services while reducing acute malnutrition and strengthening food security resilience in priority areas of the Central African Republic. The funder’s logic is explicitly nexus-based: proposals should meet urgent, life-saving needs while reinforcing local systems, coordination mechanisms, and community-level capacity so results persist beyond the emergency window. AICS emphasizes inclusion and protection outcomes, expecting gender-sensitive design and explicit measures for groups facing compounded vulnerability, including women, children under five, internally displaced people, and people with disabilities. The call also signals a localization pathway, encouraging stronger collaboration with national NGOs and balanced partnerships, alongside clear coordination with existing cluster and humanitarian actors to minimize duplication and improve coverage. Geographies: Central African Republic (Bangui, Ombella-Mpoko, Ouham, Ouham-Pende, Lim-Pende, Lobaye). Who can apply: Non-profit organizations registered with AICS, plus eligible non-profits without an office in Italy that have a pre-existing collaboration agreement with an AICS-listed organization. Funding amount: Total pool EUR €1,800,000; max EUR €800,000 (single applicant) or EUR €1,000,000 (ATS). Targeted Sectors / SDGs: Health; Focus areas: malnutrition prevention and treatment, maternal and child health, community health services, food security and resilience, localization partnerships Deadline: May 5, 2026. Learn more and apply here. This call is structured to reward partners who can link frontline service delivery to system durability and localization, not just short-term coverage gains. Contracts for Innovation in drug and alcohol addiction healthcare, Innovate UK. *Closing soon!* Innovate UK, on behalf of the Office for Life Sciences Addiction Healthcare Goals program, is procuring R&D to accelerate innovations that can improve treatment outcomes, strengthen recovery, and reduce harm and deaths linked to drug and alcohol addiction. The competition is positioned as a market-facing readiness push: selected projects are expected to advance solutions toward later-stage validation, generate evidence of user acceptability and UK market fit, and map credible routes through regulatory and certification requirements. Innovate UK signals a preference for innovations that can be field-tested in relevant UK settings and progressed to TRL 6 or 7, with practical plans for commercialization after contract completion. This structure favors applicants that can execute most work in-house, co-develop with service providers and people with lived experience, and translate technical progress into deployable tools for addiction healthcare delivery. Geographies: United Kingdom. Who can apply: Single organizations of any size (including EU, EEA, or international) leading delivery, with most work and key deliverables carried out in the UK; subcontractors for specialist skills only. Funding amount: GBP £200,000–1.5 million per project (inclusive of VAT); Total pool: GBP £20 million (across two strands). Targeted Sectors / SDGs: Health; Focus areas: Mental Health, Health Systems Strengthening, Research & Development, Technology Access. Deadline: May 6, 2026 (11:00am). Learn more and apply here. This call uses procurement to pull near-market addiction innovations toward operational proof and adoption pathways in UK services.
Cardinals start 3-game series with the Brewers
Milwaukee Brewers (18-15, fourth in the NL Central) vs. St. Louis Cardinals (20-14, third in the NL Central) St. Louis; Monday, 7:45 p.m. EDT PITCHING PROBABLES: Brewers: Chad Patrick (2-1, 2.57 ERA, 1.25 WHIP, 16 strikeouts); Cardinals: Kyle Leahy (3-3, 5.52 ERA, 1.67 WHIP, 22 strikeouts) LINE: Brewers -115, Cardinals -105; over/under is 8 1/2 runs BOTTOM LINE: The St. Louis Cardinals host the Milwaukee Brewers to start a three-game series. St. Louis is 20-14 overall and 9-9 at home.